Literature DB >> 17578758

Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids.

T Kino1.   

Abstract

Glucocorticoids have a broad array of life-sustaining functions, such as for the maintenance of the basal- and stress-related organ homeostasis. They are also frequently used as therapeutic compounds for many pathologic conditions. Thus, changes of tissue sensitivity to glucocorticoids play important roles in the physiologic conditions and are associated with and influence the course of numerous pathologic states. Changes in tissue glucocorticoid sensitivity may present on either side of an optimal range, respectively as glucocorticoid resistance or hypersensitivity, and may be generalized or tissue-specific. Recent insights into the mechanisms of the glucocorticoid receptor (GR) action indicated that the glucocorticoid signaling system is highly stochastic. Indeed, numerous factors contribute to the hormonal action at each step of the GR signaling cascade, such as ligand availability, receptor isoform expression, intracellular circulation, promoter association, attraction of cofactors, and finally clearance of the receptor from the target genes. Importantly, these regulatory mechanisms appear to be functional in tissue-, gene- and cellular biologic state-specific fashions. As an example of such phase-specific factors, we discussed influence of the cyclin-dependent kinase 5 to the GR transcriptional activity, which specifically functions in the central nervous system and may thus play an important role in the regulation of glucocorticoid action in this organ.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578758     DOI: 10.1055/s-2007-980193

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  22 in total

1.  Upregulation of nucleoside triphosphate diphosphohydrolase-1 and ecto-5'-nucleotidase in rat hippocampus after repeated low-dose dexamethasone administration.

Authors:  Dunja Drakulić; Miloš Stanojlović; Nadežda Nedeljković; Ivana Grković; Nataša Veličković; Ivana Guševac; Nataša Mitrović; Ivana Buzadžić; Anica Horvat
Journal:  J Mol Neurosci       Date:  2014-11-01       Impact factor: 3.444

2.  Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: circadian rhythm-associated alterations of glucocorticoid actions in target tissues.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Mol Cell Endocrinol       Date:  2010-12-10       Impact factor: 4.102

Review 3.  Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Endocr Dev       Date:  2010-12-16

Review 4.  Glucocorticoid receptor: implications for rheumatic diseases.

Authors:  T Kino; E Charmandari; G P Chrousos
Journal:  Clin Exp Rheumatol       Date:  2011-10-21       Impact factor: 4.473

Review 5.  Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders.

Authors:  George P Chrousos; Tomoshige Kino
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

6.  Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system.

Authors:  Shuangsong Hong; Gen Zheng; John W Wiley
Journal:  Gastroenterology       Date:  2014-09-28       Impact factor: 22.682

Review 7.  The role of glucocorticoids for spiral ganglion neuron survival.

Authors:  David Xu Jin; Zhaoyu Lin; Debin Lei; Jianxin Bao
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

8.  Role of BCL2-associated athanogene 1 in differential sensitivity of human endothelial cells to glucocorticoids.

Authors:  Eugenia Mata-Greenwood; John M Stewart; Robin H Steinhorn; William J Pearce
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-14       Impact factor: 8.311

9.  Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.

Authors:  Ege Can Serefoglu; Zafer Tandogdu
Journal:  Ther Clin Risk Manag       Date:  2010-05-25       Impact factor: 2.423

10.  STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.

Authors:  Jan Xu; Shawei Chen; Hong Chen; Qingli Xiao; Chung Y Hsu; Drew Michael; Jianxin Bao
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.